Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease.
about
How citation distortions create unfounded authority: analysis of a citation networkAPP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD).Potential mechanisms linking cholesterol to Alzheimer's disease-like pathology in rabbit brain, hippocampal organotypic slices, and skeletal muscleIn AbetaPP-overexpressing cultured human muscle fibers proteasome inhibition enhances phosphorylation of AbetaPP751 and GSK3beta activation: effects mitigated by lithium and apparently relevant to sporadic inclusion-body myositisSporadic inclusion body myositis: the genetic contributions to the pathogenesis.Oxides and apoptosis in inflammatory myopathies.Practical application of electron microscopy to neuromuscular diseases.Genetics of inclusion-body myositis.Newest pathogenetic considerations in inclusion-body myositis: possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease.The Big Eye in the 21st century: the role of electron microscopy in modern diagnostic neuropathology.Molecular markers for granulovacuolar degeneration are present in rimmed vacuoles.Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle.Proteasome inhibition and aggresome formation in sporadic inclusion-body myositis and in amyloid-beta precursor protein-overexpressing cultured human muscle fibersDiagnosis and treatment of inflammatory muscle diseases.Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies.Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology.Endoplasmic reticulum stress induces myostatin precursor protein and NF-kappaB in cultured human muscle fibers: relevance to inclusion body myositis.Invertebrate models of Alzheimer's disease.Molecular pathology and pathogenesis of inclusion-body myositis.Inclusion-body myositis associated with Alzheimer's disease.In inclusion-body myositis muscle fibers Parkinson-associated DJ-1 is increased and oxidized.Inclusion-body myositis: muscle-fiber molecular pathology and possible pathogenic significance of its similarity to Alzheimer's and Parkinson's disease brains.Inclusion body myositis: a view from the Caenorhabditis elegans muscle.Inclusion body myositis: a degenerative muscle disease associated with intra-muscle fiber multi-protein aggregates, proteasome inhibition, endoplasmic reticulum stress and decreased lysosomal degradation.Foxo/atrogin induction in human and experimental myositis.ZnT3: a zinc transporter active in several organs.Eukaryotic aggresomes: from a model of conformational diseases to an emerging type of immobilized biocatalyzers.Association study reveals novel risk loci for sporadic inclusion body myositis.Emerging roles of ER stress and unfolded protein response pathways in skeletal muscle health and disease.BACE-1, PS-1 and sAPPβ levels are increased in plasma from sporadic inclusion body myositis patients: surrogate biomarkers among inflammatory myopathies.Amyloid-beta accumulation caused by chloroquine injections precedes ER stress and autophagosome formation in rat skeletal muscle.A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's disease.Unfolding story of inclusion-body myositis and myopathies: role of misfolded proteins, amyloid-beta, cholesterol, and aging.p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis.Homocysteine-induced endoplasmic reticulum protein (Herp) is up-regulated in sporadic inclusion-body myositis and in endoplasmic reticulum stress-induced cultured human muscle fibers.NOGO is increased and binds to BACE1 in sporadic inclusion-body myositis and in A beta PP-overexpressing cultured human muscle fibers.Rabbits fed cholesterol-enriched diets exhibit pathological features of inclusion body myositis.ER stress in skeletal muscle remodeling and myopathies.Muscle biopsy.Involvement of clusterin and the aggresome in abnormal protein deposits in myofibrillar myopathies and inclusion body myositis.
P2860
Q24260685-31C28F85-A810-4DAE-A501-77A546F15EB6Q30455082-1E585750-6229-4D25-9293-2D59A475226BQ33584772-2862B3DD-C439-400D-9065-62C8E28170E5Q33601722-68674146-C26C-48D3-A5AD-1710A548D452Q33806912-D8C1BE67-18D2-40C4-8448-A3D6FB468BB5Q34465833-562AAEEB-5650-4312-8AD5-CC54D8E07861Q34577360-14155451-BEAB-4A7D-BEED-95DE30FCD35CQ34609397-A39AAFA3-9CEE-4DDE-95F2-648357A9696AQ34824832-469B1CC7-EF76-47B6-8D9B-D95524537DD1Q35026796-29498DFF-7363-4C2A-8145-27D26B94AF8FQ35060401-A26BE6D2-A1E8-4948-A781-6CC391EFE65FQ35083348-2205B914-9F89-499E-8FE8-E6D1F648CD9AQ35085041-E0307B92-8129-42E6-A54D-05C8F978136DQ35576424-53089869-3C0F-4D44-AC43-5E1A0FFC41E5Q35593441-30970710-D9D4-47A7-9B9D-B0103DDBEAECQ35747757-1DBF7663-EA84-4B09-9869-1B9E8953F4A6Q35873911-EE20A8AB-5C83-4B0C-9680-6197F2BDF62DQ36089361-90F53FB9-8489-4842-8016-0B4202EB2FE9Q36231849-33B62DD3-77CB-41C4-A069-37B5E249EC94Q36757985-D0F52237-3CD6-4691-8F5C-15CC7AE6FA3DQ36963892-721B1DF1-524F-40C7-B248-4EADB6711794Q37083992-75A71A65-D55E-42DB-8BF4-5E47807DBEE2Q37261432-CE7E2466-F2AD-4370-9835-072C266A4FB1Q37534935-EE0E8FF8-3208-4BAB-B968-F3A6600BEB56Q37701112-68DDAC02-B0C0-4EF3-878E-72FBD4A61F15Q37922106-170CF1ED-75DA-4B42-B4C2-93276193EB8DQ38622861-F06BE6CC-BDDE-44E5-BE02-A7A21E919490Q38944635-F4EF04C0-74EE-4F51-9157-2D00CF848C3DQ39125967-31AB60D1-9FD6-4B2E-BAEA-670CEE9BB15BQ39800044-726192D3-5DA6-44B8-B7CF-694A8805728AQ41939196-EC7F4841-DFE7-4399-89E5-E3CE120CB354Q42910540-A8B6BEF2-61FC-489F-B4DE-740EA38F7BBCQ44388796-A0147FB4-46EA-448C-96A1-3D6605A44425Q45967668-3D2C9B51-D4EC-4ED2-A888-382CAB96E40EQ46126818-FCD36ABA-1DAF-4BAD-9860-6A12425E464CQ46594702-8A4CBD13-B2EC-4192-9E97-12D653918532Q46794035-90254963-55B6-49ED-A50C-2223CD1F9726Q47295145-6777EA95-A7CA-4564-9809-2FFF107CA21FQ48242777-E26D4E5D-F08F-4C48-86C3-C46A2FDF188BQ53269828-1CEFF525-981A-4956-ADB8-B6FFB4D2E968
P2860
Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Inclusion-body myositis: newes ...... o aging and Alzheimer disease.
@ast
Inclusion-body myositis: newes ...... o aging and Alzheimer disease.
@en
Inclusion-body myositis: newes ...... o aging and Alzheimer disease.
@nl
type
label
Inclusion-body myositis: newes ...... o aging and Alzheimer disease.
@ast
Inclusion-body myositis: newes ...... o aging and Alzheimer disease.
@en
Inclusion-body myositis: newes ...... o aging and Alzheimer disease.
@nl
prefLabel
Inclusion-body myositis: newes ...... o aging and Alzheimer disease.
@ast
Inclusion-body myositis: newes ...... o aging and Alzheimer disease.
@en
Inclusion-body myositis: newes ...... o aging and Alzheimer disease.
@nl
P2860
P356
P1476
Inclusion-body myositis: newes ...... o aging and Alzheimer disease.
@en
P2093
P2860
P356
10.1093/JNEN/60.1.1
P577
2001-01-01T00:00:00Z